Trade Summary

4 days ago, ROTHBLATT MARTINE A, serving as Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $537.74 per share, for a total transaction value of $5,108,527.04. Following this transaction, ROTHBLATT MARTINE A now holds 40,513 shares of UTHR.

This sale represents a 19.00% decrease in ROTHBLATT MARTINE A's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 22, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 24, 2026 at 8:47 AM ET, 2 days after the trade was made.

UNITED THERAPEUTICS Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.